N-benzyl-2-(2-[(5-(dimethylamino)pentyl]thio)-3-phenyl-3,4-dihydroquinazolin-4-yl)acetamide

ID: ALA4645813

PubChem CID: 156019467

Max Phase: Preclinical

Molecular Formula: C30H36N4OS

Molecular Weight: 500.71

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)CCCCCSC1=Nc2ccccc2C(CC(=O)NCc2ccccc2)N1c1ccccc1

Standard InChI:  InChI=1S/C30H36N4OS/c1-33(2)20-12-5-13-21-36-30-32-27-19-11-10-18-26(27)28(34(30)25-16-8-4-9-17-25)22-29(35)31-23-24-14-6-3-7-15-24/h3-4,6-11,14-19,28H,5,12-13,20-23H2,1-2H3,(H,31,35)

Standard InChI Key:  AVURAPCJQDDGMZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
    5.6859  -14.5237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6848  -15.3432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3928  -15.7522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3910  -14.1148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0996  -14.5201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0985  -15.3407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8047  -15.7498    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5166  -15.3427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5177  -14.5221    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8070  -14.1085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8070  -13.2913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0993  -12.8827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0993  -12.0655    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3916  -13.2913    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6839  -12.8827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9762  -13.2912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2696  -12.8816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5624  -13.2895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5620  -14.1076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2746  -14.5160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9789  -14.1058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2231  -15.7533    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.9320  -15.3467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6385  -15.7572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3474  -15.3506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0539  -15.7612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7628  -15.3546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4693  -15.7652    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.2264  -14.1152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9316  -14.5302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6398  -14.1240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6422  -13.3059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9305  -12.8957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2252  -13.3043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4671  -16.5823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1782  -15.3585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
  8 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
  9 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 28 35  1  0
 28 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4645813

    ---

Associated Targets(Human)

CACNA1I Tclin Voltage-gated T-type calcium channel alpha-1I subunit (425 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CACNA1H Tclin Voltage-gated T-type calcium channel alpha-1H subunit (1913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CACNA1G Tclin Voltage-gated T-type calcium channel alpha-1G subunit (1361 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 500.71Molecular Weight (Monoisotopic): 500.2610AlogP: 6.41#Rotatable Bonds: 11
Polar Surface Area: 47.94Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.79CX LogP: 6.42CX LogD: 4.06
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.31Np Likeness Score: -0.93

References

1. Nam Y, Ryu KD, Jang C, Moon YH, Kim M, Ko D, Chung KS, Gandini MA, Lee KT, Zamponi GW, Lee JY..  (2020)  Synthesis and cytotoxic effects of 2-thio-3,4-dihydroquinazoline derivatives as novel T-type calcium channel blockers.,  28  (11): [PMID:32327350] [10.1016/j.bmc.2020.115491]

Source